| Last Price | Today's Change | 52-Week Range | Trading Volume |
|---|---|---|---|
| 33.74 | 0.00 (0.00%) | 24.17 - 35.96 | 3.8 thousand (Below Avg) |
Market data as of 4:05PM 06/17/13. Quotes are delayed by at least 15 min.
| Open | -- |
|---|---|
| Previous Close | 33.74 |
| Day's Range | -- - -- |
| Market Cap | 923.9M |
| Avg Volume (10 Day) | 79.3K |
| Price/Earnings (Trailing 12 Mo.) | 23.7x |
| Earnings Per Share (Trailing 12 Mo.) | 1.41 |
| Dividend Yield | 0.055 (0.33%) |


These seven metrics are a snap to calculate, thanks to Quicken.com's One-Click Scorecard. Our goal with this tool is to help you evaluate potential investment candidates and eliminate those equities that aren't up to snuff. One-Click Scorecard won't do all the homework necessary for you to reach a decision, but it will help you develop a list of quality stocks to watch and study further.
| Performed well consistently? | Fail |
|---|---|
| Avoids excess debt? | Pass |
| Converting sales to profits? | Fail |
| Shareholder's money handled rationally? | Pass |
| Increased shareholder value? | Pass |
| Consistently increased owner earnings? | Pass |
| Sells at 25% discount to intrinsic value? | Pass |


These eight metrics are a snap to calculate, thanks to Quicken.com's One-Click Scorecard. Our goal with this tool is to help you evaluate potential investment candidates and eliminate those equities that aren't up to snuff. One-Click Scorecard won't do all the homework necessary for you to reach a decision, but it will help you develop a list of quality stocks to watch and study further.
| Pays a cash dividend? | Fail |
|---|---|
| Room to increase dividends? | Pass |
| Increased earnings over time? | Pass |
| Borrows within reasonable limits? | Pass |
| Stock is undervalued? | Fail |
| Have investors caught on? | Fail |
| Has support of institutional investors? | Pass |
| Has sufficient liquidity? | Pass |
Cantel Medical Reports EPS of $0.33 vs. $0.30 on 8% Sales Increase for Third Quarter Ended April 30, 2013
PR Newswire - Thursday 06/06/2013 8:30 AM ET
Cantel Medical Corp. To Hold Conference Call To Discuss Results for Its Third Quarter Ended April 30, 2013
PR Newswire - Friday 05/31/2013 8:30 AM ET
Cantel Medical To Present At The Deutsche Bank 38th Annual Health Care Conference
PR Newswire - Monday 05/20/2013 3:00 PM ET
| CMN | Industry Range | |
|---|---|---|
| Revenue Growth (1yr) | 9.61% | |
| Net Income Growth (1yr) | 46.66% | |
| Total Debt/Equity | 0.34 | |
| LT Debt/Equity | 0.31 | |
| Earnings Yield | 4.22% | |
| Price/Sales | 2.23 |
| Company | Last | Change |
|---|---|---|
| Luminex Corp | 19.98 | -0.79% |
| Endologix Inc | 13.07 | 0.00% |
| Integra LifeSciences Holdings Corp | 36.92 | +1.54% |
| ICU Medical Inc | 74.03 | 0.00% |
| Tornier NV | 16.75 | +3.59% |
Data is delayed by at least 15 min.